Tau pathology is considered an accurate correlate of AD-related neurodegeneration, as the extent and topological distribution of tau accumulation mirrors the disease’s clinical course more faithfully than other biomarkers (Knopman et al., 2021). Here, MAPT is linked to Alzheimer disease.